Epstein Secrets

del Capital S.A.E. Egypt Christopher J. Elias President and Chief Executive Officer PATH (Programme for USA Appropriate Technology in Health) Johan Eliasch Chairman and Chief Executive Officer Head NV United Kingdom Olafur Eliasson Artist Studio Olafur Eliasson Denmark Gerri Elliott Executive Vi

agement Practice Harvard Business School USA Julie Louise Gerberding President, Merck Vaccines Merck & Co. Inc. USA David R. Gergen Director, Center for Public Leadership Harvard Kennedy School USA Valery Gergiev Artistic and General Director Mariinsky Theatre Russian Federation Valerie Germain Managing Partner

del Capital S.A.E. Egypt Christopher J. Elias President and Chief Executive Officer PATH (Programme for USA Appropriate Technology in Health) Johan Eliasch Chairman and Chief Executive Officer Head NV United Kingdom Olafur Eliasson Artist Studio Olafur Eliasson Denmark Gerri Elliott Executive Vi

agement Practice Harvard Business School USA Julie Louise Gerberding President, Merck Vaccines Merck & Co. Inc. USA David R. Gergen Director, Center for Public Leadership Harvard Kennedy School USA Valery Gergiev Artistic and General Director Mariinsky Theatre Russian Federation Valerie Germain Managing Partner

es Ralph Eichler Espen Barth Eide Jérg Eigendorf Maria Eitel Stuart E. Eizenstat Daniel Ek Klas Eklund Hisham El-Khazindar Christopher J. Elias Johan Eliasch Olafur Eliasson Gerri Elliott Lawrence Elliott Michael J. Elliott Stephen Ellis Sir Vernon J. Ellis David T. Ellwood Eduardo S. Elsztain Craig Em

f Executive Officer Chief Executive Officer Managing Director, Legal and Risk Professor of Management Practice President, Merck Vaccines Director, Center for Public Leadership Artistic and General Director Managing Partner, Strategy and Business Development Managing Director, Marketing Co-Founder and Chief Executive Officer